Brief: Relief Therapeutics: Michelle Lock Assumes CEO Role On Interim Basis

MindMaze Therapeutics Holding SA

22/11/2023 07:42

Nov 22 (Reuters) - Relief Therapeutics Holding SA
 RLFB.S :
    * ANNOUNCES CEO TRANSITION
    * MICHELLE LOCK, CURRENT INDEPENDENT MEMBER OF RELIEF'S
BOARD OF
DIRECTORS, WILL BE ASSUMING ROLE OF CEO ON AN INTERIM BASIS
    * APPOINTMENT AS INTERIM CEO OF RELIEF IS EFFECTIVE
IMMEDIATELY
    * CURRENT CHIEF EXECUTIVE OFFICER (CEO), JACK WEINSTEIN,
WILL BE
STEPPING DOWN AS PART OF A LEADERSHIP TRANSITION

Source text for Eikon:  ID:nEQblMT8la 
Further company coverage:  RLFB.S 

 ((frankfurt.newsroom@thomsonreuters.com;))